The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH
- PMID:32298690
- DOI: 10.1016/j.bcp.2020.113979
The selective 5-HT2A receptor agonist 25CN-NBOH: Structure-activity relationship, in vivo pharmacology, and in vitro and ex vivo binding characteristics of [3H]25CN-NBOH
Abstract
The remarkable effects exhibited by classical psychedelics in recent clinical trials have spawned considerable interest in 5-HT2A receptor (5-HT2AR) activation as a treatment strategy for several psychiatric/cognitive disorders. In this study we have continued our development of 25CN-NBOH, one of the most 5-HT2AR-selective agonists reported to date, as a pharmacological tool for exploration of 5-HT2AR expression and functions. The importance of the 2' and 3' positions in 25CN-NBOH as structural hotspots for its 5-HT2AR activity was investigated by synthesis and pharmacological characterization of six novel analogs at 5-HT2AR and 5-HT2CR in binding and functional assays. While the 5-HT2AR activity of 25CN-NBOH was retained in 3'-methyl, 2',3'-chroman, 2',3'-dihydrofuran and 2',3'-furan analogs, the 3'-methoxy and 3'-ethyl analogs displayed substantially lower binding affinities and agonist potencies than 25CN-NBOH. Interestingly, the 2',3'-substitution pattern was also a key determinant of agonist efficacy, as all six analogs exhibited low-efficacy partial agonism or de facto antagonism at the 5-HT2AR in the functional assays. Systemic administration of 25CN-NBOH and its close structural analog 25CN-NBMD induced robust head-twitch response in mice, a well-established behavioural effect of 5-HT2AR activation in vivo, and 25CN-NBOH mediated robust reductions in the activity of mice in an anxiety-related marble burying assay, which supports the proposed beneficial effects of 5-HT2AR activation on disorders characterized by cognitive rigidity. Finally, tritiated 25CN-NBOH exhibited high 5-HT2AR binding affinity (KD ~1 nM) and selectivity against 5-HT2BR and 5-HT2CR in equilibrium and kinetic binding studies of the recombinant receptors, and in concordance [3H]25CN-NBOH displayed substantial specific, ketanserin-sensitive binding to cortex and small levels of binding to choroid plexus in rat brain slices in autoradiography studies. In conclusion, this work delineates the subtle molecular determinants of the 5-HT2AR activity in 25CN-NBOH, substantiates the potential in this compound and its analogs as tools for in vivo studies of the 5-HT2AR, and introduces a novel selective agonist radioligand as another potentially valuable tool for future explorations of this receptor.
Keywords: 25CN-NBOH; 5-HT(2A) receptor (5-HT(2A)R); 5-HT(2A)R-selective agonist; Serotonin receptors; [(3)H]25CN-NBOH.
Copyright © 2020 Elsevier Inc. All rights reserved.
Similar articles
- Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties ofN-(2-Hydroxybenzyl)-2,5-Dimethoxy-4-Cyanophenylethylamine (25CN-NBOH), a Highly Selective and Brain-Penetrant 5-HT2A Receptor Agonist.Jensen AA, McCorvy JD, Leth-Petersen S, Bundgaard C, Liebscher G, Kenakin TP, Bräuner-Osborne H, Kehler J, Kristensen JL.Jensen AA, et al.J Pharmacol Exp Ther. 2017 Jun;361(3):441-453. doi: 10.1124/jpet.117.239905. Epub 2017 Mar 30.J Pharmacol Exp Ther. 2017.PMID:28360333
- Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.Halberstadt AL, van der Zee JVF, Chatha M, Geyer MA, Powell SB.Halberstadt AL, et al.Psychopharmacology (Berl). 2019 Feb;236(2):821-830. doi: 10.1007/s00213-018-5118-y. Epub 2018 Nov 17.Psychopharmacology (Berl). 2019.PMID:30448990Free PMC article.
- Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.Fantegrossi WE, Gray BW, Bailey JM, Smith DA, Hansen M, Kristensen JL.Fantegrossi WE, et al.Psychopharmacology (Berl). 2015 Mar;232(6):1039-47. doi: 10.1007/s00213-014-3739-3. Epub 2014 Sep 17.Psychopharmacology (Berl). 2015.PMID:25224567Free PMC article.
- 25CN-NBOH: A Selective Agonist for in vitro and in vivo Investigations of the Serotonin 2A Receptor.Märcher Rørsted E, Jensen AA, Kristensen JL.Märcher Rørsted E, et al.ChemMedChem. 2021 Nov 5;16(21):3263-3270. doi: 10.1002/cmdc.202100395. Epub 2021 Aug 21.ChemMedChem. 2021.PMID:34288515Review.
- "Selective" serotonin 5-HT2A receptor antagonists.Casey AB, Cui M, Booth RG, Canal CE.Casey AB, et al.Biochem Pharmacol. 2022 Jun;200:115028. doi: 10.1016/j.bcp.2022.115028. Epub 2022 Apr 4.Biochem Pharmacol. 2022.PMID:35381208Free PMC article.Review.
Cited by
- Structure-Activity Assessment and In-Depth Analysis of Biased Agonism in a Set of Phenylalkylamine 5-HT2A Receptor Agonists.Pottie E, Poulie CBM, Simon IA, Harpsøe K, D'Andrea L, Komarov IV, Gloriam DE, Jensen AA, Kristensen JL, Stove CP.Pottie E, et al.ACS Chem Neurosci. 2023 Aug 2;14(15):2727-2742. doi: 10.1021/acschemneuro.3c00267. Epub 2023 Jul 20.ACS Chem Neurosci. 2023.PMID:37474114Free PMC article.
- Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures.Cassiano LMG, Oliveira MDS, de Barros WA, de Fátima Â, Coimbra RS.Cassiano LMG, et al.Heliyon. 2023 Jun 28;9(7):e17720. doi: 10.1016/j.heliyon.2023.e17720. eCollection 2023 Jul.Heliyon. 2023.PMID:37449113Free PMC article.
- Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A.Cameron LP, et al.J Neurosci. 2023 Nov 8;43(45):7472-7482. doi: 10.1523/JNEUROSCI.1384-23.2023.J Neurosci. 2023.PMID:37940583Free PMC article.Review.
- Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.Cumming P, Scheidegger M, Dornbierer D, Palner M, Quednow BB, Martin-Soelch C.Cumming P, et al.Molecules. 2021 Apr 22;26(9):2451. doi: 10.3390/molecules26092451.Molecules. 2021.PMID:33922330Free PMC article.Review.
- Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT2A Receptor Agonists.Poulie CBM, Pottie E, Simon IA, Harpsøe K, D'Andrea L, Komarov IV, Gloriam DE, Jensen AA, Stove CP, Kristensen JL.Poulie CBM, et al.J Med Chem. 2022 Sep 22;65(18):12031-12043. doi: 10.1021/acs.jmedchem.2c00702. Epub 2022 Sep 13.J Med Chem. 2022.PMID:36099411Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources